Opiant Pharmaceuticals Investor Relations Material
Latest events
Q2 2022
Opiant Pharmaceuticals
Investor Presentation
16 Feb, 2023
Q4 2022
16 Feb, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Opiant Pharmaceuticals Inc
Access all reports
Opiant Pharmaceuticals Inc. specialized in the development of treatments for addiction and drug overdose. The company focused on advancing pharmaceutical therapies based on proprietary formulations and delivery methods. Its work involved both research and regulatory development activities. The company was headquartered in Santa Monica, California, and its shares were listed on the NASDAQ.
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
OPNT
Country
🇺🇸 United States